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Xanthone photocageHydrogen sulﬁde (H2S) has multiple physiological roles, for example, in vasodilation and inﬂammation. It
is a highly reactive gas under ambient conditions, so controllable H2S donors are required for studying its
biological functions. Here, we describe the design, synthesis and application of a H2S donor (SPD-2) that
utilizes xanthone photochemistry to control H2S release. H2S generation from SPD-2 was completely
dependent on UVA-irradiation (325–385 nm), as conﬁrmed by methylene blue assay and by the use of
a H2S-selective ﬂuorescent probe. SPD-2 was conﬁrmed to provide controlled H2S delivery in live cells,
and should be suitable for various biological applications.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).(a)
(b)Hydrogen sulﬁde (H2S), like nitric oxide (NO) and carbon
monoxide (CO), is a gaseous physiological signal transmitter1 that
has roles in multiple processes, including vascular smooth muscle
relaxation,2 neurotransmission3 and regulation of inﬂammation.4 It
is biologically synthesized from L-cysteine and/or L-homocysteine
by cystathionine-b-synthase (CBS),5 cystathionine-c-lyase (CSE)6
and 3-mercaptopyruvate sulfur transferase (3MST) coupled with
cysteine aminotransferase (CAT).7 Recently, a novel H2S biosyn-
thetic pathway from D-cysteine, involving 3-MST and D-amino acid
oxidase (DAO), has also been reported.8 These enzymes have been
demonstrated to inﬂuence a wide range of physiological and path-
ological processes.9,10
In biological research on H2S, inorganic sulﬁde salts, such as
Na2S and NaSH have been widely used as H2S sources. However,
these sources have substantial disadvantages for examination of
the physiological functions of H2S. For example, H2S generation is
very fast, and precise control of the release rate and dosage is
not feasible. These compounds cannot mimic biological H2S
release, which is thought to be relatively slow and continuous.
Therefore, controllable H2S donors are required for detailed inves-
tigation of the physiological functions of H2S and for potential ther-
apeutic applications. We focused on photocontrollable H2S donors,
since photolysis-induced H2S release has the potential to allow
precise control of the location, timing and dosage of release.Some photolysis-inducing H2S donors, based on geminal-dithiol
structure, have already been reported.11 However, it is difﬁcult to
control the rate of H2S release from these donors because the for-
mation of H2S depends on hydrolysis of geminal dithiol in aqueous
media. Recently, we have reported a H2S derivative doubly pro-
tected with a photolabile protecting group (PPG) as a photo-acti-
vatable H2S donor,12 based on ketoprofenate PPG13 which has





































Scheme 2. Synthesis of SPD-2. Reagents and conditions: (a) 2-iodobenzoic acid, Cs2CO3, CuCl, TDA-1, dioxane; (b) H2SO4, 85 C, 2 steps 52%; (c) H2SO4, MeOH, 96%; (d)
paraformaldehyde, K2CO3, DMSO, 56%; (e) MsCl, NEt3, CH2Cl2, quant.; (f) LiBr, MeCN, 36%; (g) sodium sulﬁde nonahydrate, toluene, H2O, C16H33(C4H9)3P+Br-, 46%; (h) LiOH,
THF, H2O, MeOH, 84%. TDA-1 = tris[2-(2-methoxyethoxy)ethyl]amine, DMSO = dimethylsulfoxide, MsCl = methanesulfonyl chloride, THF = tetrahydrofuran.
Figure 1. Release of H2S from SPD-2 (100 lM) in PBS, pH 7.4, with 1% DMSO as
detected by the methylene blue method. Formation of methylene blue after
irradiation of SPD-2 for various times was determined from the absorbance at
671 nm. Photoirradiation was performed at 325–385 nm and the light intensity was
set at 2.0 mW/cm2. The data represent the average of three independent experi-
ments with standard deviations.
Figure 2. Fluorescence measurement for detection of H2S generation using HSip-1.
The concentration of SPD-2 was 100 lM and that of HSip-1 was 1 lM in phosphate
buffer, pH 7.4, containing 1% DMSO. Fluorescence emission was measured at
516 nm with excitation at 491 nm. Measurements were made after incubation of
HSip-1: (a) without SPD-2 or irradiation; (b) with SPD-2 but without irradiation;
(c) without SPD-2 after irradiation for 300 s; (d) with SPD-2 after irradiation for 300
seconds. Photoirradiation was performed at 325–385 nm and the light intensity
was set at 2.0 mW/cm2. The data represent the average of three independent
experiments with standard deviations.
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ity, formation of benign photo-products and a higher release rate
than o-nitrobenzyl PPG,14 the most widely used PPG. However,
SPD-1 shows maximum absorbance at 260 nm (Fig. S1b), and con-
sequently the efﬁciency of H2S release from SPD-1 is insufﬁcient
for application in living cells when UV-A (330–380 nm), widely
equipped in some microscopies, is utilized as an uncaging light
source. Therefore, we set out to design a new photo-induced H2S
donor suitable for cellular application. Recently, xanthone PPGs
have been reported as next-generation carbanion-mediated PPGs15
with excellent absorption in the UVA region (>320 nm). We
designed a novel photo-controllable H2S donor, SPD-2, by utilizing
xanthone PPG to protect H2S directly (Scheme 1b). SPD-2 showed
superior photochemical properties to the ketoprofenate-type H2S
donor, and we conﬁrmed that it is available for photo-controlled,
site-speciﬁc H2S release in live cells.SPD-2 was synthesized as shown in Scheme 2. Preparation of
the synthetic intermediate was performed as described previ-
ously.15 Xanthone derivative 5 was prepared by Ullmann conden-
sation of o-iodobenzoic acid and 2-(4-hydroxyphenyl)propanoic
acid (3), followed by acid-catalyzed Friedel–Crafts type reaction.
After esteriﬁcation of 5, hydroxymethylation by treatment with
paraformaldehyde and K2CO3 gave the desired alcohol 7. This
was mesylated to obtain 8, which was converted to the brominated
derivative 9. Then, sulﬁde 10was synthesized by using sodium sul-
ﬁde nonahydrate. In this reaction, 2-(prop-1-en-2-yl)-9H-xanthen-
9-one (Scheme 1b, the proposed photoproduct 2) was obtained as a
by-product, and this was isolated for structural conﬁrmation of the
photo-product of SPD-2. Finally, hydrolysis gave the desired prod-
uct SPD-2. The structure and purity of SPD-2 were conﬁrmed by 1H
NMR, 13C NMR, mass spectrometry and elemental analysis.
Figure 3. Fluorescence images of cells treated with HSip-1 DA (30 lM) in the presence or absence of SPD-2 AM with UVA photoirradiation. The treated cells were
photoirradiated with UVA (330–380 nm) for 5 min. Representative images are shown in panels a–d: (a and b) Fluorescence images of cells treated with SPD-2 AM (a) before
and (b) after photoirradiation; (c and d) images of cells without SPD-2 AM (c) before and (d) after photoirradiation. Photoirradiation was performed at the area indicated by
the circle. All cells were treated with HSip-1DA. Scale bar = 20 lm. (e) Ratio of average ﬂuorescence intensities inside the indicated circle at 10 and 0 min (FIafter/FIbefore) after
5 min UV-irradiation (330–380 nm) in D-PBS. Data represent means and standard deviation (n = 3). ⁄P < 0.05 versus control.
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lized methylene blue assay, a widely used colorimetric method for
H2S detection.16 In this study, a 100 lM solution of SPD-2 in pH 7.4
phosphate buffer buffer (containing 1% DMSO as a co-solvent) was
prepared. When a solution of SPD-2 was subjected to UV irradia-
tion at 325–385 nm for various durations, H2S release was clearly
irradiation-dependent (Figs. 1, S2). When 100 lM SPD-2 was irra-
diated for 400 s, the concentration of released H2S was determined
as 47 lM, while SPD-1 released only 15 lM H2S under the same
conditions.10 This result indicated that SPD-2 is a more efﬁcient
H2S donor than SPD-1, presumably because the maximum absorp-
tion range of SPD-2 is well matched to the wavelength of the irra-
diating light, whereas that of SPD-1 is not (Fig. S1).
For further conﬁrmation of photo-dependent H2S release, we
employed HSip-1, a H2S-selective ﬂuorescent probe that utilizes
azamacrocyclic copper (II) ion complex chemistry to control the
ﬂuorescence.17 As shown in Figure 2, the ﬂuorescence intensity of
HSip-1 was dramatically increased upon irradiation in the presence
of 100 lM SPD-2 in 100 mM PBS, pH 7.4 containing 1% DMSO as a
co-solvent (an aliquot was taken after irradiation for 300 s). Almost
no ﬂuorescence increment was observed in the controls (Fig. 2a–c).
We conﬁrmed the formation of the photoproduct 2, illustrated
in Scheme 1b. Photodecomposition of SPD-2 was monitored by
HPLC. As shown in Figure S3, the peak of SPD-2 decreased and a
new peak around 14 min was observed in the irradiated solution.
The absorbance and retention time of the newly formed peak
was identical to those of authentic 2. This result conﬁrmed that
photolysis-induced H2S generation proceeded in the expected
manner.
Next, we examined the stability of SPD-2. A solution of 100 lM
SPD-2 in pH 7.4 phosphate buffer was incubated for 1 month at
37 C in the dark. However, no decomposition was detected by
means of HPLC (data not shown). This result suggested that SPD-
2 is remarkably stable in the dark and has good light-responsive-
ness as a H2S photo-donor.
Next, we applied this donor to living cells (Fig. 3). However, SPD-
2 probably has poor membrane permeability due to the hydrophilic
carboxylmoieties. Therefore, thesemoietieswere acetoxymethylat-
ed to improve the membrane permeability. Acetoxymethylated
SPD-2 (SPD-2 AM) should permeate cell membrane and be intracel-
lularly hydrolyzed to SPD-2. HEK293 cells were incubated with
100 lM SPD-2 AM and 30 lM HSip-1 DA (membrane-permeableHSip-1) in Dulbecco’s modiﬁed Eagle’s medium (DMEM) for
30 min, then washed with Dulbecco’s phosphate-buffered saline
(D-PBS), and photo-irradiated for 5 min at the site indicated by the
circle in Figure 3a. Upon photoirradiation, ﬂuorescence enhance-
ment was observed (Fig. 3b and e), while little ﬂuorescence incre-
ment was observed in cells outside the photoirradiated area.
Additionally, SPD-2 did not show strong toxicity at lowmicromolar
level which is anticipated as the active dose of H2S donors.18
(Fig. S4). Under the same conditions, SPD-1 showed no ﬂuorescence
enhancement (data not shown), probably because its efﬁciency of
H2S release on irradiation at this wavelength was much lower than
that of SPD-2. These results indicated that SPD-2 is suitable for use in
live cells.
In conclusion, we have developed a novel photo-controllable
H2S donor, SPD-2, using xanthonate PPG. Generation of H2S from
SPD-2 can be precisely controlled by irradiation at 325–385 nm
(UVA). This donor is available both in aqueous solution and in live
cells. We expect that SPD-2 will be a useful tool for elucidating a
wide range of biological functions of H2S.
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